STOCK TITAN

Trulieve Announces January 2022 Investor Conference Participation

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Trulieve Cannabis Corp. (OTCQX: TCNNF) announced its participation in upcoming investor conferences in January 2022. Key events include the ICR Conference on January 10, where CEO Kim Rivers will engage in a fireside chat, followed by the ATB Capital Markets conference on January 13 with President Steve White participating in a panel discussion. Finally, CEO Kim Rivers will also speak at the Needham Growth Conference on January 14. Operating in 11 states, Trulieve is recognized for its innovative products and customer-focused approach.

Positive
  • Participation in three significant investor conferences in January 2022, enhancing visibility.
  • Leadership engagement at these conferences by both CEO Kim Rivers and President Steve White.
Negative
  • None.

TALLAHASSEE, Fla., Jan. 5, 2022 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, today announced upcoming participation in various investor conferences in January.

  • ICR Conference, January 10, 2022: Founder and CEO Kim Rivers will participate in a fireside chat and investor meetings.
  • ATB Capital Markets 10th Annual Institutional Investor Conference, January 13, 2022: President Steve White will participate in a panel discussion and investor meetings.
  • Needham 24th Annual Growth Conference, January 14, 2022: Founder and CEO Kim Rivers will participate in a panel discussion and investor meetings.

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S. operating in 11 states, with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve 
Instagram: @Trulieve 
Twitter: @Trulieve 

Investor Contact
Christine Hersey, Director of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Rob Kremer, Executive Director of Corporate Communications
+1 (404) 218-3077
Robert.Kremer@Trulieve.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/trulieve-announces-january-2022-investor-conference-participation-301454501.html

SOURCE Trulieve Cannabis Corp.

FAQ

What conferences is Trulieve participating in January 2022?

Trulieve will participate in the ICR Conference on January 10, ATB Capital Markets Conference on January 13, and the Needham Growth Conference on January 14, 2022.

Who from Trulieve will speak at the ICR Conference?

CEO Kim Rivers will participate in a fireside chat at the ICR Conference.

What is the stock symbol for Trulieve?

Trulieve trades on the OTCQX market under the symbol TCNNF.

Which states does Trulieve operate in?

Trulieve operates in 11 states, with leading market positions in Arizona, Florida, and Pennsylvania.

TRULIEVE CANNABIS CORP

OTC:TCNNF

TCNNF Rankings

TCNNF Latest News

TCNNF Stock Data

1.04B
121.05M
4.89%
5.44%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Quincy